Hepatology

Class of drug

bile duct disease that is characterized by abnormal dilatation of the intrahepatic bile ducts

artificial channel within the liver

organ system comprising the liver, gall bladder and bile ducts

Clonorchiasis is an infectious disease caused by the Chinese liver fluke (Clonorchis sinensis) and two related species. Clonorchiasis is a known risk factor for the development of cholangiocarcinoma, a neoplasm of the biliary system.

human disease

human disease

intrahepatic cholestasis characterized by reversible cholestasis typically occurring in the second or third trimester of pregnancy, elevated serum aminotransferases and bile acid level and resolution of symptoms by 2 to 3 weeks after delivery

human disease

Hepatectomy is the surgical resection (removal of all or part) of the liver. While the term is often employed for the removal of the liver from a liver transplant donor, this article will focus on partial resections of hepatic tissue and hepatoportoenterostomy.

maneuver during a physical examination as part of the abdominal examination

A hepatotoxin (Gr., hepato = liver) is a toxic chemical substance that damages the liver.

Human disease

Hepatocellular adenoma (HA) is a rare benign tumor of the liver

medical test involving removal of tissue sample from the liver

Aceruloplasminemia is a rare autosomal recessive disorder in which the liver can not synthesize the protein ceruloplasmin properly, which is needed to transport copper around the blood. Copper deficiency in the brain results in neurological problems that generally appear in adulthood and worsen over time.

medical condition

polyp that involves the gall bladder

Glucuronidation is often involved in drug metabolism of substances such as drugs, pollutants, bilirubin, androgens, estrogens, mineralocorticoids, glucocorticoids, fatty acid derivatives, retinoids, and bile acids. These linkages involve glycosidic bonds.

medical condition

systemic fibroinflammatory disease, associated with elevated serum IgG4 levels in about 70% of cases

lipid metabolism disorder characterized by an enzymatic defect that prevents long-chain fatty acids from being transported into the mitochondria

benign hepatic vascular tumors

hepatic vascular disease that is characterized by obstruction of some of the small veins of the liver

Scoring system for assessing the severity of chronic liver disease

medical procedure

autosomal recessive metabolic disorder affecting enzymes involved in bilirubin metabolism

non-cancerous tumor of the liver

medical condition

Human disease

amino acid metabolic disorder that involves defective proteins called carnitine transporters, which bring carnitine into cells and prevent its escape from the body preventing the body cannot utilize fats for energy

Cholangiography is the imaging of the bile duct (also known as the biliary tree) by x-rays and an injection of contrast medium. __TOC__

elevations of the levels of transaminases in the serum

detoxification treatment for liver failure

a fold in the visceral peritoneum between lobes of the liver

Hepatoprotection or antihepatotoxicity is the ability of a chemical substance to prevent damage to the liver. This is opposite to hepatotoxicity.

Fanconi-Bickel glycogenosis (FBG) is a rare glycogen storage disease characterized by hepatorenal glycogen accumulation, severe renal tubular dysfunction and impaired glucose and galactose metabolism

attaches the liver to the abdominal wall

dyskeratosis congenita that has material basis in an X-linked recessive mutation of TINF2 on chromosome 14q12

malignant tumor in the liver coming from another organ affected by cancer

Adenomyomatosis is a benign condition characterized by hyperplastic changes of unknown cause involving the wall of the gallbladder.

in anatomy, thin tube that collects bile secreted by hepatocytes

aggressive, rare cancer

chronic liver disease in children

criterion

regrowth of lost or destroyed liver

Erythroferrone is a protein hormone encoded in humans by the ERFE gene. Erythroferrone is produced by erythroblasts, inhibits the production of hepcidin in the liver, and so increases the amount of iron available for hemoglobin synthesis. Skeletal muscle secreted ERFE has been shown to maintain systemic metabolic homeostasis.

medical diagnostic method

human disease

A hepatoportoenterostomy or Kasai portoenterostomy is a surgical treatment performed on infants with Type IVb choledochal cyst and biliary atresia to allow for bile drainage. In these infants, the bile is not able to drain normally from the small bile ducts within the liver into the larger bile ducts that connect to the gall bladder and small intestine.

gastrointestinal system disease that is located in the liver and/or biliary tract

acidophilic globule of cells that represents a dying hepatocyte

organ

medical condition